Literature DB >> 15777417

Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.

Naresh Mondraty1, C Laird Birmingham, Stephen Touyz, Viktoria Sundakov, Lucy Chapman, Pierre Beumont.   

Abstract

OBJECTIVE: Recovery from anorexia nervosa is confounded by intrusive anorectic cognitions and rituals. It has been observed that olanzapine, an atypical antipsychotic, can reduce this anorexic rumination. A pilot study was designed to test the effectiveness of olanzapine in this role.
METHODS: A randomized trial of olanzapine versus chlorpromazine, with anorexic rumination as the primary outcome, was conducted. Of the 26 patients who presented, 15 were randomized in a balanced block design, eight to olanzapine and seven to chlorpromazine.
RESULTS: Only the olanzapine group had a significant reduction in the degree of rumination.
CONCLUSION: Olanzapine may be of benefit in anorexia nervosa by causing a reduction in anorexic rumination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777417     DOI: 10.1080/j.1440-1665.2004.02154.x

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  28 in total

1.  Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa.

Authors:  Mark L Norris; Wendy Spettigue; Annick Buchholz; Katherine A Henderson; Rebecca Gomez; Danijela Maras; Isabelle Gaboury; Andy Ni
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-21       Impact factor: 2.576

Review 2.  Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Authors:  Timothy D Brewerton
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

3.  Psychotropic usage by patients presenting to an academic eating disorders program.

Authors:  Karuna Mizusaki; Daniel Gih; Christina LaRosa; Rebekah Richmond; Renee D Rienecke
Journal:  Eat Weight Disord       Date:  2018-06-07       Impact factor: 4.652

Review 4.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

5.  Olanzapine use in adolescent anorexia nervosa.

Authors:  K Dennis; D Le Grange; J Bremer
Journal:  Eat Weight Disord       Date:  2006-06       Impact factor: 4.652

Review 6.  Anorexia nervosa.

Authors:  Kathleen Kara Fitzpatrick; James Lock
Journal:  BMJ Clin Evid       Date:  2011-04-11

7.  Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.

Authors:  Vikas Duvvuri; Taya Cromley; Megan Klabunde; Kerri Boutelle; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2011-02-22       Impact factor: 4.861

Review 8.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

9.  Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.

Authors:  M Aragona
Journal:  Eat Weight Disord       Date:  2007-09       Impact factor: 4.652

Review 10.  Anorexia nervosa.

Authors:  James D Lock; Kathleen Kara Fitzpatrick
Journal:  BMJ Clin Evid       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.